President Clinton, Pfizer, and Mylan Announce New Agreements to Lower Prices of Medicines
President Bill Clinton announced two important and complementary agreements today to enable better, more affordable treatments for patients on second-line antiretroviral (ARV) therapy for HIV/AIDS in the developing world. For the first time, a second-line regimen of four ARVs will be available for under $500 annually.
Original Source of President Clinton, Pfizer, and Mylan Announce New Agreements to Lower Prices of Medicines
